This course will provide a comprehensive introduction to the transformative impact of artificial intelligence on drug safety and monitoring. This course covers the fundamentals of AI technology, its applications in pharmacovigilance and practical insights into leveraging AI tools for efficient adverse event reporting, signal detection and risk management. Through a mix of theoretical knowledge and practical examples, participants will gain the understanding of available AI solutions in pharmacovigilance practices as well as current regulatory advances.
Benefits of attending
- Learn how AI can streamline pharmacovigilance processes, reducing manual effort and increasing productivity
- Discover AI's potential to improve the accuracy of adverse event detection and reporting
- Understand application of AI in signal detection
- Gain insights into how AI can help maintain and enhance compliance with regulatory requirements
- Stay updated with the latest trends and advancements in AI applications within the pharmaceutical industry
- Discover the ethical considerations and best practices for implementing AI in pharmacovigilance
Certifications:
- CPD: 3 hours for your records
- Certificate of completion
Speakers
Alina Panourgia,
Composite PharmaAlina Panourgia is an experienced QA/PV Auditor and Regulatory Affairs professional, with a career spanning various regions.
Alina started her career in SEA working at the manufacturing site leading Quality Control/Regulatory Affairs department. She still prepares companies for inspections and provides trainings.
Since relocating to the Middle East in 2015, Alina has worked as a freelancer, collaborating with UK, US and EU companies on PV projects. Additionally, Alina has overseen regulatory submissions and pharmacovigilance activities in the MENA, LATAM and CIS regions.
Alina is a frequent speaker at international forums, conferences and training programs, sharing her expertise on various topics in pharmacovigilance, regulatory affairs and quality improvements.
She has presented at GCC Regulatory Affairs/PV Summits, Drug Safety Symposiums and other significant industry events within MENA region.
Who Should Attend
- Pharmacovigilance specialists
- Drug safety officers
- Regulatory affairs professionals
- Clinical research associates
- Medical affairs personnel
- Data scientists working in healthcare and pharmaceuticals
